As over 200 companies compete to unveil the first successful covid-19 vaccine. Now the main issue of concern is if the vaccine has unexpected side effects then who would foot the bill in poor countries. Watch report.

Who will be liable for vaccine side effects? Question on financial claims still uncovered | COVID-19 Pandemic

Experts in the US say remdesivir is effective in stopping the virus. But, lawmakers want to know how Gilead will price the drug. Will remdesivir be a 'cure' that no one can afford? WION's Palki Sharma brings you an assessment.

Gravitas: Will remdesivir be a 'cure' that no one can afford?

Scientists across the world are racing against time to develop a vaccine for coronavirus. With the 2nd phase of the vaccine trial beginning in China, the country could now be heading the race. Watch report.

China begins 2nd phase of COVID-19 vaccine trial

35 companies and institutions are working on vaccines to fight the Wuhan virus. Are we closer to a potential drug? WION's Palki Sharma brings you up to speed with the latest developments.

Gravitas: Are we getting closer to a cure? | Wuhan Coronavirus

The coronavirus has affected even the mightiest countries of the world taking the global death toll to 48,276. Now according to some US researchers, there may be a ray of hope. BCG vaccine may offer protection against the deadly coronavirus. Watch report:

India's battle against COVID-19 Pandemic: BCG vaccine to offer COVID-19 protection

India has also developed an indigenous testing kit for spotting the COVID-19 infection. The kit is said to be simple and cheap and has also received the approval from the top medical virology research bodies in the country. Watch report:

India develops COVID-19 testing kits: Govt, private labs to receive kits within weeks